Balloon mitral commissurotomy in juvenile rheumatic mitral stenosis: a ten-year clinical and echocardiographic actuarial results

Size: px
Start display at page:

Download "Balloon mitral commissurotomy in juvenile rheumatic mitral stenosis: a ten-year clinical and echocardiographic actuarial results"

Transcription

1 European Heart Journal (2003) 24, Balloon mitral commissurotomy in juvenile rheumatic mitral stenosis: a ten-year clinical and echocardiographic actuarial results H. Gamra*, F. Betbout, K. Ben Hamda, F. Addad, F. Maatouk, Z. Dridi, S. Hammami, M. Abdellaoui, H. Boughanmi, T. Hendiri, M. Ben Farhat Cardiology Department, Fattouma Bourguiba University Hospital, 5000 Monastir, Tunisia Received 31 January 2003; revised 3 April 2003; accepted 18 April 2003 KEYWORDS Balloon mitral commissurotomy; Young; Follow-up; Restenosis Introduction Mitral stenosis is rarely seen in children and adolescents except in developing countries where rheumatic fever is still endemic. 1 3 It is well known that mitral stenosis at this age is often associated with frequent episodes of pulmonary edema prompting the need for therapeutic intervention. 1 5 Until the mid-1980s, surgical closed or * Corresponding author. Habib Gamra, MD, Cardiology Department, Fattouma Bourguiba University Hospital-5000 Monastir, Tunisia. Tel.: ; Fax: address: hgamra@rns.tn (H. Gamra). Aims To evaluate the safety, efficacy and long-term actuarial results of balloon mitral commissurotomy in young patients with severe rheumatic mitral stenosis. Methods and results Event-free survival and freedom from restenosis were analyzed in 110 patients 20 years old or younger (group 1) and compared with those of 554 adults (group 2). Young patients were less frequently in atrial fibrillation (6% vs 35%, P<0.001) and had less mitral valve deformities (echo score 5.9±2.1 vs 7.5±3.0, P<0.0001). Mitral valve area index by 2D-echo was of 0.66±0.1 cm 2 /m 2 in group 1 and 0.67±0.1 cm 2 /m 2 in group 2 (P=ns) and was larger in group 1 (1.5 vs 1.3 cm 2 /m 2 ) after the procedure (P<0.0001). There were more complications in group 2 (8.4% vs 0%, P=0.01). Procedural success was obtained in 110 (100%) patients of group 1 vs 501 (92%) patients of group 2 (P<0.0001). At follow-up mitral valve area index was 1.34 cm 2 /m 2 in group 1 and 1.16 cm 2 /m 2 in group 2 (P<0.0001). At 10 years, freedom from restenosis was 61% in group 1 vs 71% in group 2 (P=0.35) and event-free survival was 74% and 69% respectively (P=0.15). Conclusion Balloon mitral commissurotomy is safe and effective in young with rheumatic mitral stenosis and provides better immediate results than in adults. However long-term outcome was similar between the 2 groups: 2/3 of patients were alive and free from clinical events at 10 years Published by Elsevier Ltd on behalf of The European Society of Cardiology. open commissurotomy was the only available treatment. However, mitral valve surgery in children and adolescents, in addition to its acute risks, has the added disadvantage that because the initial surgery is performed at an early age, reintervention may be necessary 10 to 15 years later. In adults, balloon mitral commissurotomy yielded similar results than those obtained after open surgical commissurotomy 6,7 and better results than those obtained after closed commissurotomy. 6 Therefore, balloon mitral commissurotomy appears to be an attractive alternative in that particular setting where mitral valve is pliable with minimal calcifications X/03/$ - see front matter 2003 Published by Elsevier Ltd on behalf of The European Society of Cardiology. doi: /s x(03)

2 1350 H. Gamra et al. Table 1 Baseline characteristics Group 1 (n=110) Group 2 (n=544) P Age (years) 16±2.8 37±11.9 <0.001 Female 75 (68%) 399 (73%) ns Atrial fibrillation 6 (6%) 189 (35%) <0.001 Previous commissurotomy 12 (10.8%) 98 (18%) ns Body surface area (m2) 1.44± ±0.18 < NYHA a III 76 (69%) 373 (69%) ns Echo-score 5.9± ±3.0 <0.001 Mitral regurgitation Grade 1 8 (7.2%) 65 (21.0%) ns Grade 2 1 (0.9%) 6 (1.1%) ns Left atrial size (mm) 43±9 55±11 P<0.001 a NYHA=New York Heart Association Although this procedure has been extensively used in adult and elderly patients with both short and long-term follow-up results abundantly reported, 8 18 there is no much published data on its long-term outcome in juvenile patients. Thus the purpose of this study was to evaluate the immediate and long-term (up to 10 years) results of balloon mitral commissurotomy in patients 20 years old or younger. Furthermore, we also sought to compare and contrast these results with those obtained in the adult population. Methods Study population Clinical characteristics A total of 654 patients with severe rheumatic mitral stenosis underwent balloon mitral commissurotomy in our institution between November 1987 and December Of these patients, 110 were 20 year-old or younger (Group 1) while the remainder (n=544) constituted Group 2. The baseline characteristics of both groups are shown in Table 1. Mean age was of 16 years (range: 8 20) in group 1 vs 37 years (range: 21 76) in group 2. There were more patients with atrial fibrillation in the adult population. Patients were equally symptomatic in both groups prior to the procedure and two thirds of each group were in class III or IV of New-York Heart Association functional classification. Echocardiographic evaluation All patients underwent a 2D echo-doppler examination before the procedure. Mitral valve structure was assessed using Wilkins score 19 which was less favorable in adults than in young patients as shown in Table 1. An echo score >8 was found in 16 (15%) patients of group 1 vs 201 (37%) patients of group 2 (P=0.0001). Mitral valve area was determined by 2D echo planimetry. Because of the difference in body surface area between the young and adult populations, mitral valve area index was considered for comparison. Mitral regurgitation was assessed by color Doppler using Helmcke classification 20 which is based on a scale of 1 to 4 according to the degree of jet extension into the left atrium. Prior to the procedure, special care was taken to rule out any clots in the left atrium or the left atrial appendage by transesophageal echocardiography that was systematically performed in every patient since April In addition transesophageal echocardiography provided additional information on the mitral valve structure and the severity of mitral regurgitation. Echo-Doppler examination was repeated within 24 h after the procedure to evaluate mitral valve area, to assess the severity of mitral regurgitation and to detect the presence of atrial septal defect. Mitral commissurotomy procedure After obtaining an informed consent from the patient or the parents, the procedure was performed under local anesthesia. Right and left heart catheterization was performed using respectively a 7 Fr sheath for the right femoral vein and a 6 Fr sheath for the left femoral artery. Intracardiac pressures were recorded and left ventriculography performed in all patients (except for 52 pregnant women), before and after the procedure. Transseptal puncture was performed using a Brockenbrough needle and 7 Fr Mullins sheath through the right femoral vein. Double balloon technique was used in 96 (87.3%) patients of group 1 and 455 (83.6%) patients of group 2 whereas Inoue technique was utilized in

3 Balloon mitral commissurotomy in the young (12.7%) patients of group 1 and 89 (16.4%) of group 2 (P=ns). Balloon size was selected according to the body surface area. The procedure with either technique was performed as previously described. 11,14 Follow-up evaluation After discharge, patients were requested, as part of the research protocol to return every six months during the two first years and at yearly intervals thereafter for clinical and echo-doppler evaluation. Data were additionally obtained for clinical care purposes if indicated. At a mean follow-up of 66±23 months (range: 6 to 144), clinical and echo-doppler data was available in all group 1 patients. For group 2, data was available in 534 (98%) patients at a mean follow-up of 64±16 months (range: 1 134). Mitral valve restenosis was defined as a mitral valve area index <0.9 cm 2 /m 2 by 2D echo. The threshold of 0.9 derives from the usual threshold of valve area in adults of 1.5 cm2 divided by the mean body surface area among our adult population which was of 1.7 m2. A clinical event was defined as: (1) death from any cause, (2) mitral valve replacement, (3) repeat balloon mitral commissurotomy, or (4) New- York Heart Association class III or IV. Procedural death and emergent mitral valve replacement following the procedure were included in the follow-up clinical events. To prevent rheumatic fever, patients were given benzathine penicillin G up to the age of 35 years. Statistical analysis Data are expressed as mean±standard deviation. Continuous variables were analysed using unpaired Student's t test and categorical variables using Chisquare and Fisher exact test. Comparison of variables before and after the procedure was carried out using paired t test. Twenty-six baseline clinical, echocardiographic and procedural variables were tested to determine significant univariate correlates of immediate success in the overall group. Variables with a significance level of P<0.25 were entered in a multiple stepwise logistic regression model to identify independent predictors of procedural success with a final significance level of P<0.05. Kaplan Meier analysis was used to determine survival rate, event-free survival and restenosisfree survival. Differences in survival rates between the two groups were analysed by the Log-rank test. To identify independent predictors of event-free Table 2 survival, in both groups, a Cox proportional hazard regression analysis using backward selection with a threshold of P<0.05 was performed. All analyses were performed using Stata software version 5.0 (Stata corporation, Texas, USA). Results Complications during the procedure in both groups Immediate results Group 1 Group 2 P Procedural death 0 3 (0.5%) ns Tamponade 0 4 (0.7%) ns Systemic embolism 0 9 (1.4%) ns Mitral regurgitation (5.5%) Total 0 46 (8.4%) 0.01 The procedure was completed in all group 1 patients and in 537 (98.7%) of group 2 patients. There was no death in the young population vs 3 in the adult population: 2 because of left ventricular perforation and 1 from a stroke that occurred during the procedure. Overall, the only complication encountered in the young population was a transient leg ischemia observed after the procedure and which was most likely related to femoral artery puncture. The list of complications in both groups is shown in Table 2. Hemodynamic parameters significantly improved in both groups as shown in Table 3 (all P<0.001). Mitral valve area by echo increased from 0.95±0.20 to 2.13±0.3 cm 2 in group 1 and from 1.06±0.2 to 2.15±0.4 cm 2 in group 2 (P=ns) Mitral valve area index by echo which was of 0.66 cm 2 /m 2 in group 1 and 0.67 cm 2 /m 2 in group 2 (P=ns) significantly increased to 1.5±0.3 and 1.3±0.3 cm 2 /m 2 respectively (P<0.001; Fig. 1). The same pattern was observed among patients with an echo score <8 (Fig. 2). Residual stenosis defined as mitral valve area index <0.9 cm 2 /m 2 after the procedure was found in 13 (2.3%) patients of group 2 vs none of group 1 patients (P=ns). No severe mitral regurgitation ( grade 3) was observed in the young group. In contrast, severe mitral regurgitation was observed in 30 (5.5%) patients of the adult group. Procedural success defined as a mitral valve area index 0.9 cm 2 /m 2 with no severe mitral regurgitation after the procedure, was obtained in 110

4 1352 H. Gamra et al. Table 3 Hemodynamic parameters before and immediately after the procedure Group 1 Group 2 P Pressures (mm Hg) Left atrium Pre 29±8 27± Post 13±6 15± Pulmonary artery (systolic) Pre 55±20 52±20 ns Post 37±15 37±14 ns Mean mitral gradient Pre 23±8 20± Post 5±3 6±4 ns Cardiac index (l/min/m 2 ) Pre 3.2± ± Post 3.7± ±0.8 <0.001 Mitral valve area (cm2) Pre 0.90± ± Post 2.2± ±0.4 ns Mitral valve area index (cm 2 /m 2 ) Pre 0.63± ±0.1 ns Post 1.57± ±0.1 <0.001 Fig. 1 Mitral valve area index before (Pre) and after (Post) balloon mitral commissurotomy and at follow-up (F/U) in both groups. Fig. 2 Mitral valve area index before (Pre) after (Post) the procedure and at follow-up (F/U) in patients with echo score 8 in both groups. (100%) patients of group 1 vs 501 (92%) patients of group 2 (P<0.001). Long-term results Event-free survival The clinical events that occurred in both groups during follow-up are shown in Table 4. In group 1, all patients were alive, and 14 of them (12.7%) had a clinical event. The remaining 96 patients were in functional class I (n=89) or II (n=7). In group 2, 97 patients (17.8%) had a clinical event including 10 additional deaths all from cardiac causes. The remaining 437 patients were alive in functional class I (n=379) or II (n=58) without further cardiac intervention. The probability of event-free survival (Fig. 3) was 90% at 5 years and 74% at 10 years in group 1 vs 83% and 69% respectively in group 2 (P=0.15). There was no univariate predictor of adverse clinical events in the young. In contrast, in the adult group, echo-score and cardiac rhythm were pre-procedural predictors whereas mitral valve area index, left atrial pressure and mitral regurgitation were post-procedural predictors of adverse clinical events (Table 5).

5 Balloon mitral commissurotomy in the young 1353 Table 4 Clinical events during follow-up in both groups Group 1 Group 2 P Death 0 13 (2.5%) ns Reintervention 14 (12.7%) 84 (15.4%) ns Redo balloon mitral commissurotomy 13 (11.8%) 33 (6%) 0.02 Mitral valve replacement 1 (0.9%) 51 (9.3%) Total 14 (12.7%) 97 (17.8%) ns Fig. 3 Freedom from clinical events by Kaplan Meier analysis. Number of patients evaluated in both groups at 3, 5, 7 and 10 years of follow-up are indicated. Table 5 Predictors of event-free survival according to univariate analysis in both groups Group 1 Group 2 Echo-score 0.9 <0.001 Sex Mitral valve area index (Pre) Mitral valve area index (Post) 0.4 <0.001 Previous commissurotomy Cardiac rhythm 0.3 <0.001 Left atrial pressure (Pre) Left atrial pressure (Post) Mitral regurgitation (Pre) Mitral regurgitation (Post) 0.6 <0.001 No patients in neither group developed symptoms suggesting recurrent rheumatic fever during follow-up. Freedom from restenosis Doppler echocardiographic follow-up results were available in all group 1 and in 514 group 2 patients (patients with significant residual mitral stenosis or early events were excluded). Mitral valve area index decreased from 1.5±0.3 to 1.3±0.3 cm 2 /m 2 but remained significantly higher compared with the baseline value (P<0.001) and with mitral valve area index in the adults which was of 1.16± 0.3 cm 3 /m 2 (P<0.001) as shown in Fig. 1. Restenosis was found in 14 (12.7%) young, 13 of whom had a successful repeat balloon mitral commissurotomy and one underwent mitral valve replacement because of associated grade 2 mitral regurgitation. Restenosis was observed in 83 adults (16.1%), 33 had a repeat procedure and 20 underwent mitral valve replacement. The remaining 30 patients were asymptomatic and therefore did not require reintervention. Actuarial freedom from restenosis at 5 and 10 years was 91% and 61% respectively in group 1 vs 88% and 71% in group 2 (P=0.35, Fig. 4). No predictor of restenosis was found in group 1 using the univariate analysis. However in group 2, cardiac rhythm, echo-score and previous commissurotomy were preprocedural predictors whereas left atrial pressure and mitral

6 1354 H. Gamra et al. Fig. 4 Freedom from restenosis by Kaplan Meier analysis. Number of patients evaluated in both groups at 3, 5, 7 and 10 years of follow-up are indicated. regurgitation were post procedural predictors of restenosis. Discussion Previous reports of balloon mitral commissurotomy in young populations examined small number of patients except for Sinha et al. 33 who reported a series of 193 patients. Follow-up is often limited to weeks 22,23,28 or months 27,29 32 except for Zaki et al. 34 who reported five years follow-up results.to the best of our knowledge, our study represents the largest sample size with the longest follow-up period reported. Immediate results The immediate results of balloon mitral commissurotomy in young were better than in adults with a significant larger mitral valve area index and fewer complications; however, there was no statistically significant inter-group differences in most of the hemodynamic variables. Procedure complications were not encountered in the young. In contrast, 46 (8.4%) adult patients experienced complications (P=0.01). This is most likely related to the more favourable anatomy in the young as demonstrated by a lower echocardiographic score. In fact, the severely diseased mitral valves usually seen in adults are associated with enlarged left and right atria, thickened and sometimes calcified inter-atrial septum that makes both the atrial puncture and the balloon passage more difficult. In fact, in our population young patients had significantly smaller left atrial dimension than adults (Table 1). Furthermore, balloon placement is considerably easier across a pliable than a calcified valve. All of these factors make the procedure easier, smoother and shorter in young patients. Our results are comparable to the ones reported by others. 26,28,33,34 For example, in Bahl study, 28 the better results obtained in the children population were attributed to the more diseased subvalvular apparatus in the adult population. In order to examine whether the outcome differences in our study was solely attributable to the difference in echo-score, we compared mitral valve area index between patients with an echo-score 8 in both groups (Fig. 2). Such analysis revealed similar results to those obtained in the whole population, which supports the hypothesis that there may be a role for factors besides echo-score such as left atrial size. In addition, the typically inferior echogenicity found in the adult patients makes it more difficult to accurately assess the echoscore which thereby would be underestimated. Long-term results Event-free survival Although the difference in clinical events between the two groups was not statistically significant, there were fewer events in the young population. There was no death and the only clinical events were related to reintervention procedures for restenosis and/or significant mitral regurgitation. Kaplan Meier analysis showed that 90% and 74% of the young population vs 83% and 69% of the adult

7 Balloon mitral commissurotomy in the young 1355 population were alive and free from clinical events at 5 and 10 years of follow-up respectively. The lack of inter-group differences in survival and adverse clinical events (Figs. 3 and 4) was probably because our adult population was relatively young (mean age: 37±11.9 years). In contrast, the mean age in other published studies, particularly those from Western countries, is typically higher; for example 54±15 years in the NHLBI mitral balloon valvuloplasty registry 9 and 45±15 years in the study of Iung and colleagues. 15 Not surprisingly eventfree survival was lower in such populations with for instance a 51% freedom from clinical events at 36 months for Cohen, 8 60% at 4 years for Dean 9 and 56% at 10 years for Iung. 15 In contrast, our results are comparable to those of Zaki et al. 32 who found an event-free survival of 91% at 5 years among 46 children and adolescents. Restenosis Restenosis rate was lower although not statistically different in young vs adult patients. Restenosis, which was defined by echocardiographic criteria, did warrant a reintervention in 13 (11.8%) young vs 53 (9.7%) adults. The remaining patients were free of symptoms and therefore did not have any reintervention. Although direct comparison between our results and those of surgical commissurotomy can not be made because of the lack of published data, we believe that our data offer strong arguments for consideration of balloon mitral commissurotomy as the technique of choice for the treatment of juvenile rheumatic mitral stenosis. Further encouragement derives from the fact that all of the young patients that developed restenosis were able to undergo a successful repeat procedure. The slightly higher rate of reintervention in the young group may be explained by the fact that restenosis is more often symptomatic for patients engaged in physical activity. The lack of significant predictors of restenosis in young is most likely related to the small sample size as only 14 patients developed that event. Although there was no link between restenosis and recurrent rheumatic fever in our population, patients should be given Benzathin Penicillin G at least up to the age of 35 to prevent such an event. Reintervention Balloon mitral commissurotomy was repeated in all young patients who had restenosis. In fact, all of them had a pliable mitral valve apparatus suitable for a repeat procedure. The repeat procedure was successful in all cases. In contrast, only 33 among 82 adult patients (40.2%) had repeat balloon mitral commissurotomy. The remaining patients had calcified valves that required replacement. Of interest, none of our patients that was sent for surgery because of restenosis had a surgical open commissurotomy, suggesting patients who are not good candidates for repeat balloon mitral commissurotomy are unlikely to be good candidates for surgical commissurotomy. In summary, balloon mitral commissurotomy in young patients is effective, safe and provides better immediate results than in adults particularly with regard to acute complications. Although indexed mitral valve area was larger than in adults, freedom from restenosis and from clinical events at 10 years was not statistically significant between the two groups: 2/3 were alive and free from clinical events at 10 years.these encouraging results support the validity of this technique as a procedure of choice for the treatment of mitral stenosis especially in children and adolescents. Acknowledgements We thank Peter Whittaker, PhD, for reviewing and Jamila Rassas for preparing this manuscript. References 1. Roy SB, Bhatia ML, Lazaro EJ et al. Juvenile mitral stenosis in India. Lancet 1963;2: Reale A, Colella C, Bruno AM. Mitral stenosis in childhood: clinical and therapeutic aspects. Am Heart J 1963;66: Bhayana JN, Khanna SK, Gupta BK et al. Mitral stenosis in the young in developing countries. J Thorac Cardiovasc Surg 1974;68: Ben- Ismail M, Kafsi N, Taktak M. Commissurotomie mitrale chez l'enfant. A propos de 100 cas. Arch Mal Cœur 1978; 10: Arora R, Nair M, Rajagopal S et al. Percutaneous balloon mitral valvuloplasty in children and young adults with rheumatic mitral stenosis. Am Heart J 1989;118: Ben-Farhat M, Ayari M, Maatouk F et al. Pecutaneous balloon versus surgical closed and open mitral commissurotomy: seven-year follow-up results of a randomised trial. Circulation 1998;97: Reyes VP, Raju BS, Wynne J et al. Percutaneous balloon valvuloplasty compared with open surgical commissurotomy for mitral stenosis. N Engl J Med 1994;331: Cohen DJ, Kuntz E, Gordon SPF et al. Predictors of long-term outcome after percutaneous balloon mitral valvuloplasty. N Engl J Med 1992;327: Dean LS, Mickel M, Bonan R et al. Four-year follow-up of patients undergoing percutaneous balloon mitral comissurotomy. A report from the NHLBI balloon valvuloplasty registry. J Am Coll Cardiol 1996;28: Desideri A, Vanderperren O, Serra A et al. Long-term (9 to 33 months) echocardiographic follow-up after successful percutaneous mitral commissurotomy. Am J Cardiol 1992; 69:

8 1356 H. Gamra et al. 11. Ben- Farhat M, Betbout F, Gamra H et al. Predictors of long-term event-free survival and of freedom from restenosis after percutaneous balloon mitral commissurotomy. Am Heart J 2001;142: Palacios IF, Tuzcu ME, Weyman AE et al. Clinical follow-up of patients undergoing percutaneous mitral balloon valvotomy. Circulation 1995;91: Hernandez R, Banuelos C, Alfonso F et al. Long-term clinical and echocardiographic follow-up after percutaneous mitral valvuloplasty with the Inoue balloon. Circulation 1999; 99: Iung B, Cormier B, Ducimetiere P et al. Immediate results of percutaneous mitral commissurotomy: A predictive model on a series of 1514 patients. Circulation 1996;94: Iung B, Garbarz E, Michaud P et al. Late results of percutaneous mitral commissurotomy in a series of 1024 patients. Analysis of late clinical deterioration: frequency, anatomic findings and predictive factors. Circulation 1999;99: Pan M, Medina A, Suarez de Lezo J et al. Factors determining late success after mitral balloon valvulotomy. Am J Cardiol 1993;71: Ruiz CE, Zhang HP, Gamra H et al. Late clinical and echocardiographic follow-up after percutaneous balloon dilatation of the mitral valve. Br Heart J 1994;71: Orrange S, Kawanishi P, Lopez B et al. Actuarial outcome after catheter balloon commissurotomy in patients with mitral stenosis. Circulation 1997;95: Wilkins GT, Weymen AE, Abascal VM et al. Percutaneous balloon dilatation of the mitral valve: An analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J 1988;60: Helmcke F, Nanda NC, Hsiung MC et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 1987;75: Lock JE, Khalilullah M, Shrivastava S et al. Percutaneous catheter commissurotomy in rheumatic mitral stenosis. N Engl J Med 1985;313: Petit J, Losay J, Leriche H et al. Valvuloplastie mitrale endoluminale chez l'adulte jeune et l'enfant. A Propos de 10 cas. Arch Mal Cœur 1987;8: Aorora R, Nair M, Rajagopal S et al. Percutaneous balloon mitral valvuloplasty in children and young adults with rheumatic mital stenosis. Am Heart J 1989;118: Shrivastava S, Dev V, Vasan RS et al. Percutaneous balloon mitral valvuloplasty in juvenile rheumatic mitral stenosis. Am J Cardiol 1991;67: Natarajan D, Sharma VP, Sharma SC. Percutaneous mitral valvotomy by Inoue catheter in young patients with mitral stenosis. Am Heart J 1992;123: Essop MR, Govendrageloo K, Plessis JD et al. Balloon mitral valvotomy for rheumatic mitral stenosis in children aged <12 years. Am J Cardiol 1993;72: Fawzy ME, Mimish L, Awad M et al. Mitral balloon valvotomy in children with Inoue balloon technique: Immediate and intermediate-term results. Am Heart J 1994;127: Bahl VK, Shandra S, Kothari SS et al. Percutaneous transvenous mitral commissurotomy using Inoue catheter in juvenile rheumatic mitral stenosis. Cathet Cardivasc Diagn 1994;2: Shrivastava S, Vijaya Chandra Y, Krishnamoorthy KM et al. Mitral valvotomy with the Inoue balloon in juvenile rheumatic mitral stenosis. Am J Cardiol 1995;76: Joseph PK, Bhat A, Francis B et al. Percutaneous transvenous mitral commissurotomy using an Inoue balloon in children with rheumatic mitral stenosis. Int J Cardiol 1997; 62: Kothari SS, Kamath P, Juneja R et al. Percutaneous transvenous mitral commissurotomy using Inoue balloon in children less than 12 years. Cathet Cardiovasc Diagn 1998; 43: Mattos C, Braga SLN, Esteves CA et al. Percutaneous mitral valvotomy in patients eighteen years old and younger. Immediate and late results. Arq Bras Cardiol 1999;73: Sinha N, Kapoor A, Kumar AS et al. Immediate and followup results of Inoue balloon mitral valvotomy in juvenile rheumatic mitral stenosis. J Heart Valve Dis 1997; 6: Zaki A, Salama M, El Masry M et al. Five-year follow-up after percutaneous balloon mitral valvuloplasty in children and adolescents. Am J Cardiol 1999;83:735 9.

The role of percutaneous mitral balloon valvuloplasty

The role of percutaneous mitral balloon valvuloplasty Which Patients Benefit From Percutaneous Mitral Balloon Valvuloplasty? Prevalvuloplasty and Postvalvuloplasty Variables That Predict Long-Term Outcome Igor F. Palacios, MD; Pedro L. Sanchez, MD; Lari C.

More information

Clinical Investigations

Clinical Investigations Clinical Investigations Immediate and Long-term Results Following Balloon Mitral Valvotomy in Patients With Atrial Fibrillation Address for correspondence: Harikrishnan Sivadasan Pillai, MD Department

More information

Mædica - a Journal of Clinical Medicine

Mædica - a Journal of Clinical Medicine MAEDICA a Journal of Clinical Medicine 2013; 8(4): 333-337 Mædica - a Journal of Clinical Medicine ORIGINAL PAPERS Percutaneous Transvenous Mitral Commissurotomy in Elderly Mitral Stenosis Patients. A

More information

Balloon Dilatation of the Cardiac Valves

Balloon Dilatation of the Cardiac Valves 2 3 Balloon Dilatation of the Cardiac Valves Igor F. Palacios and Pedro L. Sánchez Percutaneous Pulmonic Valvuloplasty.............. 557 Percutaneous Mitral Balloon Valvotomy for Patients with Rheumatic

More information

Research Grant from Servier

Research Grant from Servier Disclosures ESC Paris 2011 Claire Bouleti, MD Research Grant from Servier Long-term impact of repeat Percutaneous Mitral Commissurotomy on the need for surgery in mitral stenosis. Insight from a series

More information

Late Results of Percutaneous Mitral Commissurotomy in a Series of 1024 Patients

Late Results of Percutaneous Mitral Commissurotomy in a Series of 1024 Patients Late Results of Percutaneous Mitral Commissurotomy in a Series of 1024 Patients Analysis of Late Clinical Deterioration: Frequency, Anatomic Findings, and Predictive Factors Bernard Iung, MD; Eric Garbarz,

More information

A case report: Percutaneous transcatheter treatment of Lutembacher syndrome

A case report: Percutaneous transcatheter treatment of Lutembacher syndrome A case report: Percutaneous transcatheter treatment of Lutembacher syndrome Dr. Sainath Hegde* Dr. Tukaram Aute** *Registrar, Dept of Cardiology, M.G.M Hospital, Aurangabad. **Asst. Prof, Dept of Cardiology,

More information

Long term outcome of percutaneous mitral balloon valvotomy in patients aged 70 and over

Long term outcome of percutaneous mitral balloon valvotomy in patients aged 70 and over Heart 2000;83:433 438 433 Department of Cardiology, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK N Sutaria A T Elder T R D Shaw Correspondence to: Dr Shaw Accepted 9 September 1999

More information

IS REDO MITRAL BALLOON VALVULOPLASTY AS SAFE AND EFFICIENT AS A FIRST PROCEDURE?

IS REDO MITRAL BALLOON VALVULOPLASTY AS SAFE AND EFFICIENT AS A FIRST PROCEDURE? Article Original IS REDO MITRAL BALLOON VALVULOPLASTY AS SAFE AND EFFICIENT AS A FIRST PROCEDURE? DORRA ABID, AHMED SIALA, LEILA ABID, FATENTRIKI, TARAK SALLEMI, MALEKAKROUT, MOURADHENTATI, SAMIR KAMMOUN.

More information

Changes in P-Wave After Percutaneous Mitral Valvuloplasty in Patients With Mitral Stenosis and Left Atrial Enlargement

Changes in P-Wave After Percutaneous Mitral Valvuloplasty in Patients With Mitral Stenosis and Left Atrial Enlargement Article Original Article Changes in P-Wave After Percutaneous Mitral Valvuloplasty in Patients With Mitral Stenosis and Left Atrial Enlargement José Carlos Estival Tarastchuk, Ênio Eduardo Guérios, Sônia

More information

Mitral Balloon Valvotomy for Patients With Mitral Stenosis in Atrial Fibrillation Immediate and Long-Term Results

Mitral Balloon Valvotomy for Patients With Mitral Stenosis in Atrial Fibrillation Immediate and Long-Term Results Journal of the American College of Cardiology Vol. 34, No. 4, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00310-1 Mitral

More information

For rheumatic mitral stenosis, percutaneous balloon

For rheumatic mitral stenosis, percutaneous balloon CARDIOVASCULAR Consequence of Atrial Fibrillation and the Risk of Embolism After Percutaneous Mitral Commissurotomy: The Necessity of the Maze Procedure Hiroyuki Nakajima, MD, Junjiro Kobayashi, MD, Ko

More information

Bogdan A. Popescu. University of Medicine and Pharmacy Bucharest, Romania. EAE Course, Bucharest, April 2010

Bogdan A. Popescu. University of Medicine and Pharmacy Bucharest, Romania. EAE Course, Bucharest, April 2010 Bogdan A. Popescu University of Medicine and Pharmacy Bucharest, Romania EAE Course, Bucharest, April 2010 This is how it started Mitral stenosis at a glance 2D echo narrow diastolic opening of MV leaflets

More information

Case Report Successful Treatment of Double-Orifice Mitral Stenosis with Percutaneous Balloon Mitral Commissurotomy

Case Report Successful Treatment of Double-Orifice Mitral Stenosis with Percutaneous Balloon Mitral Commissurotomy Case Reports in Cardiology Volume 2012, Article ID 315175, 4 pages doi:10.1155/2012/315175 Case Report Successful Treatment of Double-Orifice Mitral Stenosis with Percutaneous Balloon Mitral Commissurotomy

More information

Images in Cardiovascular Medicine

Images in Cardiovascular Medicine Images in Cardiovascular Medicine Management of Severe Mitral Stenosis During Pregnancy Rebecca S. Norrad, MBBS; Omid Salehian, MSc, MD, FRCPC, FACC, FAHA A 37-year-old woman originally from Iraq was referred

More information

M operations, with closed mitral valvotomy first reported

M operations, with closed mitral valvotomy first reported Comparison of Balloon Valvuloplasty With Operative Treatment for Mitral Stenosis Jeffrey M. Cohen, MHS, Donald D. Glower, MD, J. Kevin Harrison, MD, Thomas M. Bashore, MD, William D. White, MPH, L. Richard

More information

SUBJECTS AND METHODS

SUBJECTS AND METHODS Acquired Mitral Stenosis in Children under Fifteen Boonchob PONGPANICH, M.D. and Sahas LIAMSUWAN, M.D. SUMMARY The clinical and hemodynamic studies of acquired MS in 30 children under the age of 15 are

More information

Percutaneous Mitral Balloon Valvotomy. Long-term Outcome and Assessment of Risk Factors for Death and Major Events

Percutaneous Mitral Balloon Valvotomy. Long-term Outcome and Assessment of Risk Factors for Death and Major Events Original Article Percutaneous Mitral Balloon Valvotomy. Long-term Outcome and Assessment of Risk Factors for Death and Major Events Ivana Picone Borges, Edison Carvalho Sandoval Peixoto, Rodrigo Trajano

More information

Balloon mitral valvuloplasty

Balloon mitral valvuloplasty Echo for selecting and monitoring procedures in mitral valve diseases Balloon mitral valvuloplasty Eric Brochet,MD Cardiology Department Hôpital Bichat. Paris France Conflict of interest : none Balloon

More information

13/06/2018. Rheumatic Mitral Stenosis: What does the ESC Guideline say? Mitral Stenosis: Echo Assessment. Mitral Stenosis ESC Guidance 2017

13/06/2018. Rheumatic Mitral Stenosis: What does the ESC Guideline say? Mitral Stenosis: Echo Assessment. Mitral Stenosis ESC Guidance 2017 Rheumatic Mitral Stenosis: What does the ESC Guideline say? Mitral Stenosis: Echo Assessment Dave Northridge Edinburgh Heart Centre Rheumatic mitral stenosis Prosthetic mitral dysfunction Calcific/degenerative

More information

MITRAL STENOSIS. Joanne Cusack

MITRAL STENOSIS. Joanne Cusack MITRAL STENOSIS Joanne Cusack BSE Breakdown Recognition of rheumatic mitral stenosis Qualitative description of valve and sub-valve calcification and fibrosis Measurement of orifice area by planimetry

More information

score (r =0.51, P < 0.01). Mitral regurgitation did not

score (r =0.51, P < 0.01). Mitral regurgitation did not 348 lacc Vol. 17, No.2 Percutaneous Mitral Valvuloplasty in Surgical High Risk Patients THIERRY LEFEVRE, MD, RAOUL BONAN, MD, FACC, ANTONIO SERRA, MD, JACQUES CREPEAU, MD, FACC, IHOR DYRDA, MD, FACC, ROBERT

More information

754 Calcium Embolism of the Coronary Arteries Mayo Clin Proc, July 2001, Vol 76 Figure 1. Case 1. Transseptal catheterization with double-balloon infl

754 Calcium Embolism of the Coronary Arteries Mayo Clin Proc, July 2001, Vol 76 Figure 1. Case 1. Transseptal catheterization with double-balloon infl Mayo Clin Proc, July 2001, Vol 76 Calcium Embolism of the Coronary Arteries 753 Case Report Calcium Embolism of the Coronary Arteries After Percutaneous Mitral Balloon Valvuloplasty BRIAN D. POWELL, MD;

More information

Predictors of Long-Term Outcomes of Percutaneous Mitral Valvuloplasty in Patients with Rheumatic Mitral Stenosis

Predictors of Long-Term Outcomes of Percutaneous Mitral Valvuloplasty in Patients with Rheumatic Mitral Stenosis Original Article Yonsei Med J 2018 Mar;59(2):273-278 pissn: 0513-5796 eissn: 1976-2437 Predictors of Long-Term Outcomes of Percutaneous Mitral Valvuloplasty in Patients with Rheumatic Mitral Stenosis Darae

More information

Index. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Ablation, of mitral leaflets, 80 Accucinch Annuloplasty system, for mitral regurgitation, 79, 94 95 Accutrak delivery system, for CoreValve

More information

Long-term outcomes of percutaneous mitral balloon valvuloplasty versus open cardiac surgery

Long-term outcomes of percutaneous mitral balloon valvuloplasty versus open cardiac surgery Song et al Acquired Cardiovascular Disease Long-term outcomes of percutaneous mitral balloon valvuloplasty versus open cardiac surgery Jae-Kwan Song, MD, a Mi-Jeong Kim, MD, a Sung-Cheol Yun, PhD, b Suk

More information

USE OF BALLOON VALVOTOMY AS BRIDGE TO SURGERY FOR SEVERE HIGH RISK MITRAL STENOSIS

USE OF BALLOON VALVOTOMY AS BRIDGE TO SURGERY FOR SEVERE HIGH RISK MITRAL STENOSIS USE OF BALLOON VALVOTOMY AS BRIDGE TO SURGERY FOR SEVERE HIGH RISK MITRAL STENOSIS Prof. Gerald Yonga MBChB, MMed, MBA, FRCP(Edin),FESC, FACC Aga Khan University Hospital Nairobi, Kenya. RHEUMATIC HEART

More information

Percutaneous Mitral Valvotomy in a Case of Situs Inversus Totalis and Juvenile Rheumatic Critical Mitral Stenosis: Case Report

Percutaneous Mitral Valvotomy in a Case of Situs Inversus Totalis and Juvenile Rheumatic Critical Mitral Stenosis: Case Report Elmer ress Case Report J Clin Med Res. 2016;8(4):351-355 Percutaneous Mitral Valvotomy in a Case of Situs Inversus Totalis and Juvenile Rheumatic Critical Mitral Stenosis: Case Report Santosh Kumar Sinha

More information

PERCUTANEOUS TRANSLUMINAL MITRAL VALVULOPLASTY IN POST MITRAL VALVE REPAIR AND AORTIC VALVE REPLACEMENT PATIENT

PERCUTANEOUS TRANSLUMINAL MITRAL VALVULOPLASTY IN POST MITRAL VALVE REPAIR AND AORTIC VALVE REPLACEMENT PATIENT PERCUTANEOUS TRANSLUMINAL MITRAL VALVULOPLASTY IN POST MITRAL VALVE REPAIR AND AORTIC VALVE REPLACEMENT PATIENT Chandra Mani Adhikari, 1 Rabi Malla, 1 Raamesh Koirala, 2 Dipanker Prajapati, 1 Navin Gautam

More information

P technique in the treatment of certain types of mitral

P technique in the treatment of certain types of mitral Operative Findings After Percutaneous Mitral Dilation Christophe Acar, MD, Alain Deloche, MD, Pierre R. Tibi, MD, Victor Jebara, MD, Juan Carlos Chachques, MD, Jean Noel Fabiani, MD, and Alain Carpentier,

More information

Valvular Heart Disease Mitral Stenosis

Valvular Heart Disease Mitral Stenosis Valvular Heart Disease Mitral Stenosis A 75 year old woman with loud first heart sound and mid-diastolic murmur Chronic dyspnea Class 2/4 Fatigue Recent orthopnea/pnd Nocturnal palpitation Pedal edema

More information

Clinical Study Effectiveness of Percutaneous Balloon Mitral Valvuloplasty for Rheumatic Mitral Stenosis with Mild to Severe Mitral Regurgitation

Clinical Study Effectiveness of Percutaneous Balloon Mitral Valvuloplasty for Rheumatic Mitral Stenosis with Mild to Severe Mitral Regurgitation BioMed Research International Volume 2016, Article ID 3298343, 4 pages http://dx.doi.org/10.1155/2016/3298343 Clinical Study Effectiveness of Percutaneous Balloon Mitral Valvuloplasty for Rheumatic Mitral

More information

Percutaneous Management Of Prosthetic. Consultant Cardiologist Usha Mullapudi cardiac Center Hyderabad

Percutaneous Management Of Prosthetic. Consultant Cardiologist Usha Mullapudi cardiac Center Hyderabad Percutaneous Management Of Prosthetic Valve Thrombosis Dr.V.Hariram VH MD,DM DM Consultant Cardiologist Usha Mullapudi cardiac Center Hyderabad INDIA A 40 year old non diabetic non hypertensive female

More information

Original Article. Relationship Between Valve Calcification and Long-Term Results of Percutaneous Mitral Commissurotomy for Rheumatic Mitral Stenosis

Original Article. Relationship Between Valve Calcification and Long-Term Results of Percutaneous Mitral Commissurotomy for Rheumatic Mitral Stenosis Original Article Relationship Between Valve Calcification and Long-Term Results of Percutaneous Mitral Commissurotomy for Rheumatic Mitral Stenosis Claire Bouleti, MD, PhD; Bernard Iung, MD; Dominique

More information

Disclosures. ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech

Disclosures. ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech Disclosures ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech Speaker s fee Edwards Lifesciences Sanofi-Aventis Decision Making in Patients with Multivalvular

More information

profile of mitral stenosis

profile of mitral stenosis 680 Original Article The age -specific clinical and anatomical profile of mitral stenosis Ramakrishna C D, Khadar S A, George R, Jayaprakash V L, Sudhayakumar N, Jayaprakash K, Pappachan J M ABSTRACT Introduction:

More information

Interventional Cardiology. Long-Term Outcomes of Significant Mitral Regurgitation After Percutaneous Mitral Valvuloplasty

Interventional Cardiology. Long-Term Outcomes of Significant Mitral Regurgitation After Percutaneous Mitral Valvuloplasty Interventional Cardiology Long-Term Outcomes of Significant Mitral Regurgitation After Percutaneous Mitral Valvuloplasty Mi-Jeong Kim, MD; Jae-Kwan Song, MD; Jong-Min Song, MD; Duk-Hyun Kang, MD; Young-Hak

More information

Percutaneous Treatment of Valvular Heart Diseases: Lessons and Perspectives. Bernard Iung Bichat Hospital, Paris

Percutaneous Treatment of Valvular Heart Diseases: Lessons and Perspectives. Bernard Iung Bichat Hospital, Paris Percutaneous Treatment of Valvular Heart Diseases: Lessons and Perspectives Bernard Iung Bichat Hospital, Paris Euro Heart Survey on Valvular Diseases 3547 Patients with Native Valve Disease n= 1250 1000

More information

Options for my no option Patients Treating Heart Conditions Via a Tiny Catheter

Options for my no option Patients Treating Heart Conditions Via a Tiny Catheter Options for my no option Patients Treating Heart Conditions Via a Tiny Catheter Nirat Beohar, MD Associate Professor of Medicine Director Cardiac Catheterization Laboratory, Medical Director Structural

More information

Repair or Replacement

Repair or Replacement Surgical intervention post MitraClip Device: Repair or Replacement Saudi Heart Association, February 21-24 Rüdiger Lange, MD, PhD Nicolo Piazza, MD, FRCPC, FESC German Heart Center, Munich, Germany Division

More information

BCI1 6/15/05 8:26 PM Page 1. Section one Valve disease

BCI1 6/15/05 8:26 PM Page 1. Section one Valve disease BCI1 6/15/05 8:26 PM Page 1 Section one Valve disease BCI1 6/15/05 8:26 PM Page 2 BCI1 6/15/05 8:26 PM Page 3 CHAPTER 1 Mitral stenosis Kewal Krishan Talwar and Manojkumar Rohit Introduction Mitral stenosis

More information

Original Article. Short Term Outcomes of Percutaneous Pulmonary Balloon. Valvuloplasty in Adult Patients with Pulmonary Stenosis.

Original Article. Short Term Outcomes of Percutaneous Pulmonary Balloon. Valvuloplasty in Adult Patients with Pulmonary Stenosis. Short Term Outcomes of Original Article Percutaneous Pulmonary Balloon CABM, FICMS ( med), FICMS (cardiol)* Yassen Hadi AI-Ugaidy FICMS ( med ), FICMS ( cardiol )* Tahsin A.Alkmani FICMS (med), FICMS (cardiol)*

More information

Case Report Hemostasis of Left Atrial Appendage Bleed With Lariat Device

Case Report Hemostasis of Left Atrial Appendage Bleed With Lariat Device 273 Case Report Hemostasis of Left Atrial Appendage Bleed With Lariat Device Amena Hussain MD, Muhamed Saric MD, Scott Bernstein MD, Douglas Holmes MD, Larry Chinitz MD NYU Langone Medical Center, United

More information

Usefulness of Echocardiography in the Prediction of Early Results of Catheter Balloon Mitral Valvuloplasty

Usefulness of Echocardiography in the Prediction of Early Results of Catheter Balloon Mitral Valvuloplasty Usefulness of Echocardiography in the Prediction of Early Results of Catheter Balloon Mitral Valvuloplasty Shoa-Lin LIN, M.D., Mau-Song CHANG, M.D.,* Guan-Woei LEE, M.D., Tsui-Leih Hsu, M.D., Ju-Pin PAN,

More information

Advantage of lnoue Balloon Catheter in Mitral Balloon Valvotomy: Experience With 220 Consecutive Patients

Advantage of lnoue Balloon Catheter in Mitral Balloon Valvotomy: Experience With 220 Consecutive Patients Catheterization and Cardiovascular Diagnosis 38:%14 (1996) Advantage of lnoue Balloon Catheter in Mitral Balloon Valvotomy: Experience With 220 Consecutive Patients Mohammed E. Fawzy, FRCP, Layth Mimish,

More information

Transcatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data

Transcatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data Transcatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data Echo Florida 2013 Jonathan J. Passeri, M.D. Co-Director, Heart Valve Program Director,

More information

*Please see amendment for Pennsylvania Medicaid at the end

*Please see amendment for Pennsylvania Medicaid at the end 1 of 12 Number: 0477 Policy *Please see amendment for Pennsylvania Medicaid at the end of this CPB. I. Aetna considers percutaneous balloon dilation (valvuloplasty) of severe rheumatic mitral valve stenosis

More information

First Transfemoral Aortic Valve Implantation In Bulgaria - Crossing The Valve With The Device Is Not Always

First Transfemoral Aortic Valve Implantation In Bulgaria - Crossing The Valve With The Device Is Not Always ISPUB.COM The Internet Journal of Cardiology Volume 9 Number 2 First Transfemoral Aortic Valve Implantation In Bulgaria - Crossing The Valve With The Device Is Not T D, J P. Citation T D, J P.. First Transfemoral

More information

Presenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose

Presenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose Presenter Disclosure Patrick O. Myers, M.D. No Relationships to Disclose Aortic Valve Repair by Cusp Extension for Rheumatic Aortic Insufficiency in Children Long term Results and Impact of Extension Material

More information

Percutaneous Mitral Valve Repair

Percutaneous Mitral Valve Repair Percutaneous Mitral Valve Repair MitraClip: Procedure, Data, Patient Selection Chad Rammohan, MD FACC Director, Cardiac Cath Lab El Camino Hospital Mountain View, California Mitral Regurgitation MitraClip

More information

From Throat Ache to Heartache A Tale of Rheumatic Fever Through Time and Across Continents Joshua Wynne, MD, MBA, MPH Vice President for Health

From Throat Ache to Heartache A Tale of Rheumatic Fever Through Time and Across Continents Joshua Wynne, MD, MBA, MPH Vice President for Health From Throat Ache to Heartache A Tale of Rheumatic Fever Through Time and Across Continents Joshua Wynne, MD, MBA, MPH Vice President for Health Affairs Dean, UND SMHS Professor of Medicine A Real Story

More information

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Innovative Procedures, Devices & State of the Art Care for Arrhythmias, Heart Failure & Structural Heart Disease October 8-10,

More information

TAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con

TAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con TAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con Dimitrios C. Angouras, MD, FETCS Associate Professor of Cardiac Surgery National and Kapodistrian University of Athens,

More information

Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine

Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine Mitral regurgitation, regurgitant flow between the

More information

Implantation of Cardioverter Defibrillator After Percutaneous Closure of Atrial Septal Defect

Implantation of Cardioverter Defibrillator After Percutaneous Closure of Atrial Septal Defect The Ochsner Journal 10:27 31, 2010 f Academic Division of Ochsner Clinic Foundation Implantation of Cardioverter Defibrillator After Percutaneous Closure of Atrial Septal Defect Anas Bitar, MD, Maria Malaya

More information

Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated?

Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated? Ann Thorac Cardiovasc Surg 2013; 19: 428 434 Online January 31, 2013 doi: 10.5761/atcs.oa.12.01929 Original Article Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should

More information

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles

More information

IMAGES. in PAEDIATRIC CARDIOLOGY

IMAGES. in PAEDIATRIC CARDIOLOGY IMAGES in PAEDIATRIC CARDIOLOGY Images Paediatr Cardiol. 2005 Jan-Mar; 7(1): 12 17. PMCID: PMC3232568 Stent implantation for coarctation facilitated by the anterograde trans-septal approach N Sreeram and

More information

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision Prof. Pino Fundarò, MD Niguarda Hospital Milan, Italy Introduction

More information

Clinical material and methods. Departments of 1 Cardiology and 2 Anatomy, Gaziantep University, School of Medicine, Gaziantep, Turkey

Clinical material and methods. Departments of 1 Cardiology and 2 Anatomy, Gaziantep University, School of Medicine, Gaziantep, Turkey Interatrial Block and P-Terminal Force: A Reflection of Mitral Stenosis Severity on Electrocardiography Murat Yuce 1, Vedat Davutoglu 1, Cayan Akkoyun 1, Nese Kizilkan 2, Suleyman Ercan 1, Murat Akcay

More information

480 April 2004 PACE, Vol. 27

480 April 2004 PACE, Vol. 27 Incremental Value of Isolating the Right Inferior Pulmonary Vein During Pulmonary Vein Isolation Procedures in Patients With Paroxysmal Atrial Fibrillation HAKAN ORAL, AMAN CHUGH, CHRISTOPH SCHARF, BURR

More information

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve

More information

TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair?

TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair? TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair? Elaine E. Tseng, MD and Marlene Grenon, MD Department of Surgery Divisions of Adult Cardiothoracic and Vascular and Endovascular

More information

Revista Portuguesa de. Cardiologia. Portuguese Journal of Cardiology.

Revista Portuguesa de. Cardiologia. Portuguese Journal of Cardiology. Rev Port Cardiol. 2012;31(1):19-25 Revista Portuguesa de Cardiologia Portuguese Journal of Cardiology www.revportcardiol.org ORIGINAL ARTICLE Mean pulmonary arterial pressure after percutaneous mitral

More information

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More?

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More? CIPG 2013 Transcatheter Aortic Valve Replacement- When Is Less, More? James D. Rossen, M.D. Professor of Medicine and Neurosurgery Director, Cardiac Catheterization Laboratory and Interventional Cardiology

More information

Echocardiographic Guidance During Placement of the Buttoned Double-Disk Device for Atrial Septa1 Defect Closure

Echocardiographic Guidance During Placement of the Buttoned Double-Disk Device for Atrial Septa1 Defect Closure Echocardiographic Guidance During Placement of the Buttoned Double-Disk Device for Atrial Septa1 Defect Closure L. LUANN MINICH, M.D., and A. REBECCA SNIDER, M.D. Department of Pediatrics, C.S. Mott Children

More information

A novel approach to the diagnosis of left atrial appendage thrombus using contrast echocardiography and power Doppler imaging

A novel approach to the diagnosis of left atrial appendage thrombus using contrast echocardiography and power Doppler imaging European Journal of Echocardiography (2008) 9, 329 333 doi:10.1093/ejechocard/jen068 A novel approach to the diagnosis of left atrial appendage thrombus using contrast echocardiography and power Doppler

More information

Indication, Timing, Assessment and Update on TAVI

Indication, Timing, Assessment and Update on TAVI Indication, Timing, Assessment and Update on TAVI Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Starr- Edwards Mechanical

More information

What is the Role of Surgical Repair in 2012

What is the Role of Surgical Repair in 2012 What is the Role of Surgical Repair in 2012 The Long-Term Results of Surgery Raphael Rosenhek Department of Cardiology Medical University of Vienna European Society of Cardiology 2012 Munich, August 27th

More information

Atrial Septal Defect Closure. Stephen Brecker Director, Cardiac Catheterisation Labs

Atrial Septal Defect Closure. Stephen Brecker Director, Cardiac Catheterisation Labs Stephen Brecker Director, Cardiac Catheterisation Labs ADVANCED ANGIOPLASTY Incorporating The Left Main 5 Plus Course Conflicts of Interest The following companies have supported educational courses held

More information

Mitral Valve Disease, When to Intervene

Mitral Valve Disease, When to Intervene Mitral Valve Disease, When to Intervene Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Current ACC/AHA guideline Stages

More information

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM The Patient with Aortic Stenosis and Mitral Regurgitation Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM Aortic Stenosis + Mitral Regurgitation?

More information

Since first successfully performed by Jatene et al, the

Since first successfully performed by Jatene et al, the Long-Term Predictors of Aortic Root Dilation and Aortic Regurgitation After Arterial Switch Operation Marcy L. Schwartz, MD; Kimberlee Gauvreau, ScD; Pedro del Nido, MD; John E. Mayer, MD; Steven D. Colan,

More information

8/31/2016. Mitraclip in Matthew Johnson, MD

8/31/2016. Mitraclip in Matthew Johnson, MD Mitraclip in 2016 Matthew Johnson, MD 1 Abnormal Valve Function Valve Stenosis Obstruction to valve flow during that phase of the cardiac cycle when the valve is normally open. Hemodynamic hallmark - pressure

More information

Tricuspid and Pulmonic Valve Disease

Tricuspid and Pulmonic Valve Disease Chapter 31 Tricuspid and Pulmonic Valve Disease David A. Tate Acquired disease of the right-sided cardiac valves is much less common than disease of the leftsided counterparts, possibly because of the

More information

Adult Echocardiography Examination Content Outline

Adult Echocardiography Examination Content Outline Adult Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 2 3 4 5 Anatomy and Physiology Pathology Clinical Care and Safety Measurement Techniques, Maneuvers,

More information

Closed mitral valvotomy was first reported by Cutler

Closed mitral valvotomy was first reported by Cutler Mitral Commissurotomy, a Technique Outdated? Long-Term Follow-up Over a Period of 35 Years Christian Detter, MD, Teddy Fischlein, MD, Christina Feldmeier, MD, Georg Nollert, MD, Hermann Reichenspurner,

More information

The production of murmurs is due to 3 main factors:

The production of murmurs is due to 3 main factors: Heart murmurs The production of murmurs is due to 3 main factors: high blood flow rate through normal or abnormal orifices forward flow through a narrowed or irregular orifice into a dilated vessel or

More information

Dr. J. R. Rawal 1 ; Dr. H. S. Joshi 2 ; Dr. B. H. Roy 3 ; Dr. R. V. Ainchwar 3 ; Dr. S. S. Sahoo 3 ; Dr. A. P. Rawal 4 ; Dr. R. A.

Dr. J. R. Rawal 1 ; Dr. H. S. Joshi 2 ; Dr. B. H. Roy 3 ; Dr. R. V. Ainchwar 3 ; Dr. S. S. Sahoo 3 ; Dr. A. P. Rawal 4 ; Dr. R. A. (6) EFFECT OF ORAL SILDENAFIL ON RESIDUAL PULMONARY ARTERIAL HYPERTENSION IN PATIENTS FOLLOWING SUCCESSFUL PERCUTANEOUS BALLOON MITRAL VALVULOPLASTY (PBMV): SHORT TERM RESULTS IN 12 PATIENTS. Dr. J. R.

More information

When Does 3D Echo Make A Difference?

When Does 3D Echo Make A Difference? When Does 3D Echo Make A Difference? Wendy Tsang, MD, SM Assistant Professor, University of Toronto Toronto General Hospital, University Health Network 1 Practical Applications of 3D Echocardiography Recommended

More information

Managing Severe Mitral Insufficiency Due To Complicated Percutaneous Balloon Mitral Valvotomy In A Pregnant Patient

Managing Severe Mitral Insufficiency Due To Complicated Percutaneous Balloon Mitral Valvotomy In A Pregnant Patient ISPUB.COM The Internet Journal of Thoracic and Cardiovascular Surgery Volume 11 Number 1 Managing Severe Mitral Insufficiency Due To Complicated Percutaneous Balloon Mitral Valvotomy In A Pregnant Patient

More information

Percutaneous Coronary Intervention and Pulmonary Balloon Valvuloplasty in a Patient With Severe Valvular Pulmonary Stenosis

Percutaneous Coronary Intervention and Pulmonary Balloon Valvuloplasty in a Patient With Severe Valvular Pulmonary Stenosis Case Report Percutaneous Coronary Intervention and Pulmonary Balloon Valvuloplasty in a 56-Year-Old Woman With Severe Valvular Pulmonary Stenosis: A Case Report Ata Firouzi 1, MD; Omid Shafe* 1, MD; Farzad

More information

Percutaneous Therapy for Calcific Mitral Valve Disease

Percutaneous Therapy for Calcific Mitral Valve Disease 31 st Annual State of the Art Echocardiography San Diego, CA February 18, 2018 5:00 5:15 PM 15 min Percutaneous Therapy for Calcific Mitral Valve Disease Muhamed Sarić MD, PhD, MPA Director of Noninvasive

More information

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators Paris, August 28 th 2011 Is TAVI the definitive treatment in high risk patients? Impact Of Coronary Artery Disease In Elderly Patients Undergoing TAVI: Insight The Italian CoreValve Registry Gian Paolo

More information

Management of Mitral Stenosis Using 2D and 3D Echo-Doppler Imaging

Management of Mitral Stenosis Using 2D and 3D Echo-Doppler Imaging JACC: CARDIOVASCULAR IMAGING VOL. 6, NO. 11, 2013 ª 2013 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-878X/$36.00 PUBLISHED BY ELSEVIER INC. http://dx.doi.org/10.1016/j.jcmg.2013.07.008 ireviews

More information

Streamlining a TAVR Procedure From screening to post TAVR care Hatim Al Lawati

Streamlining a TAVR Procedure From screening to post TAVR care Hatim Al Lawati Streamlining a TAVR Procedure From screening to post TAVR care Hatim Al Lawati Consultant Interventional Cardiology Sultan Qaboos University Hospital Muscat Oman Speaker's name: Hatim Al Lawati, SQUH -

More information

INDICATIONS AND CONTRAINDICATIONS FOR AORTIC, MITRAL, PULMONARY AND TRICUSPID BALLOON VALVOTOMY

INDICATIONS AND CONTRAINDICATIONS FOR AORTIC, MITRAL, PULMONARY AND TRICUSPID BALLOON VALVOTOMY 57 INDICATIONS AND CONTRAINDICATIONS FOR AORTIC, MITRAL, PULMONARY AND TRICUSPID BALLOON VALVOTOMY PAULO A. RIBEIRO, MD THE ADVENT of coronary angioplasty paved the way for the nonsurgical dilatation of

More information

Management of HOCM: Non-Surgical Options

Management of HOCM: Non-Surgical Options Management of HOCM: Non-Surgical Options Howard C. Herrmann, MD, FACC, MSCAI John Bryfogle Professor of Cardiovascular Medicine and Surgery Health System Director for Interventional Cardiology Director,

More information

Echocardiographic evaluation of mitral stenosis

Echocardiographic evaluation of mitral stenosis Echocardiographic evaluation of mitral stenosis Euroecho 2011 Philippe Unger, MD, FESC Erasme Hospital, ULB, Brussels, Belgium I have nothing to declare EuroHeart Survey Etiology of single native left-sided

More information

The earliest application of intracardiac imaging

The earliest application of intracardiac imaging Intracardiac Echocardiography for Structural Heart Defects A review of ICE innovations, devices, and techniques. BY ZAHID AMIN, MD; QI-LING CAO, MD; AND ZIYAD M. HIJAZI, MD The earliest application of

More information

PART II ECHOCARDIOGRAPHY LABORATORY OPERATIONS ADULT TRANSTHORACIC ECHOCARDIOGRAPHY TESTING

PART II ECHOCARDIOGRAPHY LABORATORY OPERATIONS ADULT TRANSTHORACIC ECHOCARDIOGRAPHY TESTING PART II ECHOCARDIOGRAPHY LABORATORY OPERATIONS ADULT TRANSTHORACIC ECHOCARDIOGRAPHY TESTING STANDARD - Primary Instrumentation 1.1 Cardiac Ultrasound Systems SECTION 1 Instrumentation Ultrasound instruments

More information

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know James F. Burke, MD Program Director Cardiovascular Disease Fellowship Lankenau Medical Center Disclosure Dr. Burke has no conflicts

More information

Mitral Regurgitation after Percutaneous Balloon Mitral Valvotomy in Patients with Rheumatic Mitral Stenosis: A Single-Center Study

Mitral Regurgitation after Percutaneous Balloon Mitral Valvotomy in Patients with Rheumatic Mitral Stenosis: A Single-Center Study TEHRAN HEART CENTER Original Article Mitral Regurgitation after Percutaneous Balloon Mitral Valvotomy in Patients with Rheumatic Mitral Stenosis: A Single-Center Study Naser Aslanabadi, MD, Mehrnoush Toufan,

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of percutaneous mitral valve leaflet repair for mitral regurgitation Mitral regurgitation

More information

Aortic valve implantation using the femoral and apical access: a single center experience.

Aortic valve implantation using the femoral and apical access: a single center experience. Aortic valve implantation using the femoral and apical access: a single center experience. R. Hoffmann, K. Brehmer, R. Koos, R. Autschbach, N. Marx, G. Dohmen Rainer Hoffmann, University Aachen, Germany

More information

Organic mitral regurgitation

Organic mitral regurgitation The best in heart valve disease Organic mitral regurgitation Ewa Szymczyk Department of Cardiology Medical University of Lodz, Poland I have nothing to declare Organic mitral regurgitation leaflet abnormality

More information

Aortic stenosis (AS) is common with the aging population.

Aortic stenosis (AS) is common with the aging population. New Insights Into the Progression of Aortic Stenosis Implications for Secondary Prevention Sanjeev Palta, MD; Anita M. Pai, MD; Kanwaljit S. Gill, MD; Ramdas G. Pai, MD Background The risk factors affecting

More information

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such

More information

Mitral Stenosis: A Review

Mitral Stenosis: A Review Cardiovascular Innovations and Applications Vol. x No. x (2016) x x ISSN 2009-8618 DOI 10.15212/CVIA.2016.0041 REVIEW Mitral Stenosis: A Review By C. Richard Conti, MD, MACC 1 1 Department of Medicine,

More information

Trans-septal Catheterization. December 8, Jonathan Tobis, MD Professor of Medicine Interventional Cardiology, UCLA

Trans-septal Catheterization. December 8, Jonathan Tobis, MD Professor of Medicine Interventional Cardiology, UCLA Trans-septal Catheterization December 8, 2015 Jonathan Tobis, MD Professor of Medicine Interventional Cardiology, UCLA No conflicts of interest for this talk BRK = Brockenbrough needle BRK may be easier

More information